<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The study was carried out to evaluate the effect of prophylactic single-dose intravenous <z:chebi fb="0" ids="2663">amiodarone</z:chebi> in patients undergoing valve replacement surgery </plain></SENT>
<SENT sid="1" pm="."><plain>Maintenance of sinus rhythm is better than maintenance of fixed ventricular rate in <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) especially in the presence of irritable left or right atrium because of enlargement </plain></SENT>
<SENT sid="2" pm="."><plain>Fifty-six patients with <z:hpo ids='HP_0001654'>valvular heart disease</z:hpo> with or without AF were randomly divided into two groups </plain></SENT>
<SENT sid="3" pm="."><plain>Group I or the <z:chebi fb="0" ids="2663">amiodarone</z:chebi> group (n=28) received <z:chebi fb="0" ids="2663">amiodarone</z:chebi> (3 mg/kg in 100 ml <z:mpath ids='MPATH_458'>normal</z:mpath> saline) and group II or the control group received same volume of <z:mpath ids='MPATH_458'>normal</z:mpath> saline </plain></SENT>
<SENT sid="4" pm="."><plain>The standardized protocol for cardiopulmonary bypass was maintained for <z:hpo ids='HP_0000001'>all</z:hpo> the patients </plain></SENT>
<SENT sid="5" pm="."><plain>AF occurred in 7.14% patients in group I, and in group II, 28.57% (P=0.035); <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>/<z:mp ids='MP_0006109'>fibrillation</z:mp> was observed in 21.43% patients in group I and 46.43% patients in group II (P=0.089) after release of aortic clamp </plain></SENT>
<SENT sid="6" pm="."><plain>Most of the patients in group I (92.86%) maintained sinus rhythm without cardioversion or defibrillation after release of aortic cross clamp (P=0.002) </plain></SENT>
<SENT sid="7" pm="."><plain>Defibrillation or cardio version was needed in 7.14% patients in group I and 28.57% patients in group II (P=0.078) </plain></SENT>
<SENT sid="8" pm="."><plain>A single prophylactic intraoperative dose of intravenous <z:chebi fb="0" ids="2663">amiodarone</z:chebi> decreased post bypass <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> in this study in comparison to the control group </plain></SENT>
<SENT sid="9" pm="."><plain>Single dose of intraoperative <z:chebi fb="0" ids="2663">amiodarone</z:chebi> may be used to decrease postoperative <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> in open heart surgery </plain></SENT>
</text></document>